SCHEMBL484889

SCHEMBL484889

CC1(C)Cc2ccc(C(=O)N3CCC4(CC3)CCN(c3ccncc3)CC4)cc2C1NC(=O)c1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 11/20 0.51
TSHR P16473 9/20 0.51
HIF1A Q16665 6/20 0.51
CYP2D6 P10635 4/20 0.51
CYP1A2 P05177 4/20 0.51
CYP2C9 P11712 8/20 0.45
ALDH1A1 P00352 2/20 0.44
USP2 O75604 5/20 0.43
BDKRB1 P46663 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
CYP2C19 P33261 3/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
TYK2 P29597 1/20 0.40
ACACB O00763 1/20 0.38
ACACA Q13085 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484804 0.91 CYP3A4 (0.51) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL484659 0.90 CYP3A4 (0.47) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL484610 0.88 CYP3A4 (0.48) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL484368 0.88 BDKRB1 (0.48) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL2818587 0.87 CYP3A4 (0.47) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL484807 0.86 CYP3A4 (0.47) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL484481 0.86 CYP3A4 (0.52) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL2816168 0.86 CYP3A4 (0.49) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL485223 0.86 CYP3A4 (0.51) CYP3A4TSHRHIF1ACYP2D6CYP1A2
SCHEMBL2815741 0.86 CYP3A4 (0.47) CYP3A4TSHRHIF1ACYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885TSHR 338/4885HIF1A 1157/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP3A4 3781/4885TSHR 338/4885HIF1A 1157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.